<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A group of 21 consecutive patients aged 4-20 (median 13) years was prospectively allografted using a reduced intensity preparative regimen </plain></SENT>
<SENT sid="1" pm="."><plain>The group included both malignant (<z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo>, and <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo>) and nonmalignant (<z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> and <z:e sem="disease" ids="C0162309" disease_type="Disease or Syndrome" abbrv="ALD">adrenoleukodystrophy</z:e>) conditions </plain></SENT>
<SENT sid="2" pm="."><plain>Follow-up times ranged between 16 and 1038 days </plain></SENT>
<SENT sid="3" pm="."><plain>Four of 21 patients (9.5%) developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, and 2 of them died, whereas limited <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> was observed in 2 of 15 cases </plain></SENT>
<SENT sid="4" pm="."><plain>The 100-day mortality was 19% </plain></SENT>
<SENT sid="5" pm="."><plain>Median overall survival was above 1038 days, whereas the 34-month survival was 55% </plain></SENT>
<SENT sid="6" pm="."><plain>These data show that reduced intensity stem cell transplantation in children permits rapid engraftment from siblings with little toxicity </plain></SENT>
</text></document>